Jefferies Financial Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-80,000
Closed -$1M – 1757
2023
Q2
$1M Buy
+80,000
New +$953K 0.01% 913

Other funds holding HCAT

Jefferies Financial Group's HCAT Position: Q3 2023 in Review

Jefferies Financial Group sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 80,000 shares — an estimated $1M sold.

Jefferies Financial Group first reported a position in HCAT in Q2 2023 and held it in 1 quarter. The position peaked at $1M in Q2 2023. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

  • Jefferies Financial Group reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 80,000 Health Catalyst shares in Q3 2023, an estimated $1M.
  • Jefferies Financial Group first reported a position in Health Catalyst in Q2 2023 and held it in 1 quarter.
  • Jefferies Financial Group's Health Catalyst position peaked at $1M in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.